Hepta
Detect, Monitor, and Enable Effective Treatment for Metabolic Disease
San Francisco, United States · Founded 2024 · $7.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- hepta.bio
- Total Funding
- $7.0M
- Last Round
- $6.7M SeedNov 2025
- Rounds
- 2
About
Hepta is an AI-native liquid biopsy company focused on non-invasive diagnostics for metabolic liver disease. Its platform interprets epigenetic patterns in cell-free DNA from a standard blood draw to reveal liver biology, enabling earlier detection and treatment of MASH (metabolic dysfunction-associated steatohepatitis). Founded by former Illumina, GRAIL, and Google leaders, Hepta is headquartered in San Francisco.
Summary
Hepta is a Healthcare company based in San Francisco, United States, founded in 2024. It has raised $7.0M in total across 2 rounds, most recently a $6.7M Seed round in Nov 2025. Investors include Felicis Ventures, Illumina Ventures and Contrarian Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe